The World Bank lowered its China growth forecast for the year from 4.3 percent predicted in June to 2.7 percent due to the impact of the pandemic and property sector weaknesses on its economy.
The institution also slashed its forecast for next year from 8.1 percent down to 4.3 percent.
Many analysts believe that China's GDP growth target of around 5.5 percent for the year is now unattainable.
According to the World Bank, outbreaks and growth slowdowns in China have been followed by uneven recoveries.
Disruption to businesses has continued in China as cases surge and some restrictions remain in place.
Health officials have acknowledged that since bulk testing criteria were removed, official data no longer accurately reflect domestic infections.
The IMF forewarned last week that it will likely also reduce its predictions for China, blaming a sustained rise in cases.
The fund revised its growth forecast for China in October, lowering it to 3.2 percent this year, the lowest level in decades from the 4.4 percent it expected the previous year.
According to IMF chief Kristalina Georgieva, they are very likely to downgrade the growth projections for China, both for 2022 and 2023,
As China moves forward with the reopening, experts worry that it is ill-prepared to handle the next wave of diseases since millions of susceptible elderly people have not yet had all of the recommended vaccinations.


South Korea Central Bank Warns of Rising Financial Stability Risks Amid Won Volatility
Taiwan Stock Market Ends Higher as Semiconductor and Energy Shares Lead Gains
IMF Reaches Staff-Level Agreement With Egypt, Opening Path to $3.8 Billion in Funding
Asian Stock Markets Trade Flat as Holiday Liquidity Thins and BOJ Minutes Watched
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
BOJ Governor Signals Gradual Rate Hikes as Japan’s Inflation Nears 2% Target
FDA Approves Mitapivat for Anemia in Thalassemia Patients
Yen Stabilizes Near Lows as Japan Signals Readiness to Intervene Amid Dollar Weakness
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
U.S. Stock Index Futures Steady After S&P 500 Hits Record on Strong Economic Data
Novartis to Acquire Avidity Biosciences for $12 Billion to Strengthen Rare Muscle Disorder Portfolio
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
RBA Signals Possible Interest Rate Hike in 2026 as Inflation Pressures Persist
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training 



